Canada markets closed

INO Aug 2024 2.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
At close: 03:40PM EDT
Full screen
Previous Close0.1000
Open0.1000
Bid0.0000
Ask0.0000
Strike2.00
Expire Date2024-08-16
Day's Range0.1000 - 0.1000
Contract RangeN/A
Volume1
Open Interest162
  • PR Newswire

    INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

    INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.

  • PR Newswire

    INOVIO Reports Inducement Grants Under Inducement Plan

    INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the "Inducement Plan").

  • GuruFocus.com

    Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

    Explore key financial outcomes and strategic updates from Inovio Pharmaceuticals Inc's first quarter of 2024, signaling robust progress and operational efficiency.